Analyst Ratings for Endo Pharmaceuticals Holdings Inc (endp)
endp Rating Summary
endp Price Target Summary
- Highest: $45.00 (ThinkEquity)
- Lowest: $22.00 (Piper Jaffray)
- Average: $35.92
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$35.92 (+6.8%)
Avg. $ Target:
$35.92 (+6.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2013 | Buckingham Research | Upgrade | Buy (Neutral) |
41.00 (N/A) |
33.48 | 33.62 | 0.42% | Details |
| 5/13/2013 | CRT Capital | Downgrade | Fairly Valued (Buy) |
N/A (N/A) |
34.97 | 33.62 | -3.86% | Details |
| 5/13/2013 | William Blair | Downgrade | Market Perform (Outperform) |
36.00 (43.00) |
34.97 | 33.62 | -3.86% | Details |
| 5/13/2013 | Lazard Capital | Downgrade | Sell (Neutral) |
N/A (N/A) |
34.97 | 33.62 | -3.86% | Details |
| 5/8/2013 | Cowen | Downgrade | Underperform (Neutral) |
N/A (N/A) |
38.21 | 33.62 | -12.01% | Details |
| 4/11/2013 | Janney Montgomery Scott | New Coverage | Neutral (N/A) |
34.00 (N/A) |
34.61 | 33.62 | -2.86% | Details |
| 4/10/2013 | Standpoint Research | Downgrade | Buy (Hold) |
N/A (N/A) |
34.98 | 33.62 | -3.89% | Details |
| 2/25/2013 | Piper Jaffray | Downgrade | Underweight (Neutral) |
22.00 (28.00) |
28.04 | 33.62 | 19.9% | Details |
| 2/7/2013 | RBC Capital | Downgrade | Underperform (Sector Perform) |
24.00 (25.00) |
31.00 | 33.62 | 8.45% | Details |
| 1/31/2013 | Oppenheimer | Downgrade | Perform (Outperform) |
N/A (N/A) |
31.66 | 33.62 | 6.19% | Details |
| 12/14/2012 | Needham & Company » Updated 1/4/2013 |
Downgrade | Underperform (Hold) |
N/A (N/A) |
26.65 | 33.62 | 26.15% | Details |
| 5/2/2012 | Cantor Fitzgerald | Downgrade | Hold (N/A) |
39.00 (N/A) |
34.66 | 33.62 | -3% | Details |
| 1/6/2012 | ThinkEquity | New Coverage | Buy (N/A) |
45.00 (N/A) |
34.44 | 33.62 | -2.38% | Details |
| 8/15/2011 | Collins Stewart | Downgrade | Neutral (N/A) |
N/A (N/A) |
33.50 | 33.62 | 0.36% | Details |
| 4/29/2011 | Duncan Williams | Downgrade | Buy (N/A) |
N/A (N/A) |
40.00 | 33.62 | -15.95% | Details |
